Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is maple cinnamon French toast, a yummy concoction that has quickly become one of our favorites. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day, and please do stay in touch. We are always happy to make new pen pals. …
A new generation of Covid-19 vaccines that can be inhaled or sprayed up the nose — instead of taken by injection — will begin rolling out in Asia, though just how effective they are remains to be seen, The Wall Street Journal explains. Regulators in China and India have green-lighted distribution of vaccines delivered through the mouth or nose, a delivery that scientists say holds the promise of more potent protection against Covid-19 by better reducing infections and preventing the disease’s spread among vaccinated people because they work in the nose and lungs where transmission first happens.
Catalent, one of the largest contract manufacturers in the pharmaceutical industry, was cited by the U.S. Food and Drug Administration for a series of quality control failures at a facility in Bloomington, Ind., the same plant where the company helps produce two Covid-19 vaccines, STAT writes. The issues prompted the agency to delay distribution of Moderna booster shots, although their release has now reportedly been authorized. Following a recent month-long inspection, the agency scolded Catalent for various problems, such as failing to investigate unexplained discrepancies in batches of products and to ensure that product sampling and testing met quality control criteria.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect